News Alexion signs R&D deals with two Nordic biotechs Alexion has signed a deal with two Nordic biotechs to bolster its pipeline of potential rare disease drugs.
Market Access Sponsored Bridging research and clinical guidelines – interactive stra... Medical affairs is evolving. Understanding how to harness real-world data and digital insights is essential.
